Laura Prendergast
Stock Analyst at Raymond James
(1.75)
# 2,123
Out of 4,667 analysts
7
Total ratings
40%
Success rate
-6.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MURA Mural Oncology | Initiates: Strong Buy | $18 | $3.37 | +434.12% | 1 | Oct 4, 2024 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.50 | +540.00% | 2 | Aug 14, 2024 | |
| BDTX Black Diamond Therapeutics | Initiates: Outperform | $20 | $2.43 | +723.05% | 1 | Jul 31, 2024 | |
| THRD Third Harmonic Bio | Initiates: Outperform | $18 | $11.62 | +54.91% | 1 | Jun 7, 2024 | |
| RVMD Revolution Medicines | Upgrades: Strong Buy | $36 → $48 | $57.07 | -15.89% | 2 | Apr 10, 2024 |
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $3.37
Upside: +434.12%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.50
Upside: +540.00%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $2.43
Upside: +723.05%
Third Harmonic Bio
Jun 7, 2024
Initiates: Outperform
Price Target: $18
Current: $11.62
Upside: +54.91%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36 → $48
Current: $57.07
Upside: -15.89%